Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)
Public ClinicalTrials.gov record NCT00491556. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r) in Adolescents With CD4 + T Cells > 350 Cells/mm3 Initiating HAART
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study proposes to evaluate a pre-DHHS guideline of HAART initiation and then de-intensification management strategy in adolescents with mild immunosuppression and compare changes in CD4% from baseline to week 48 and then during de-intensification.
Study identification
- NCT ID
- NCT00491556
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 102 participants
Conditions and interventions
Conditions
Interventions
- Early Initiation of Highly Active Anti-Retroviral Therapy Procedure
- Standard Care Procedure
Procedure
Eligibility (public fields only)
- Age range
- 18 Years to 24 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2007
- Primary completion
- May 31, 2013
- Completion
- May 31, 2013
- Last update posted
- Mar 28, 2017
2007 – 2013
United States locations
- U.S. sites
- 22
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Hopsital of Los Angeles | Los Angeles | California | 90027 | — |
| University of Southern California - IMPAACT Site | Los Angeles | California | 90033 | — |
| University of California at San Francisco | San Francisco | California | 94118 | — |
| Children's Hospital of Denver - IMPAACT Site | Aurora | Colorado | 80045 | — |
| Children's National Medical Center | Washington D.C. | District of Columbia | 20010 | — |
| Howard University - IMPAACT Site | Washington D.C. | District of Columbia | 20060 | — |
| Children's Diagnostic and Treatment Center | Fort Lauderdale | Florida | 33316 | — |
| University of Miami | Miami | Florida | 33101 | — |
| University of Southern Florida College of Medicine | Tampa | Florida | 33606 | — |
| Stoger Hospital of Cook County | Chicago | Illinois | 60612 | — |
| Childrens Memorial Hospital | Chicago | Illinois | 60614 | — |
| Tulane Medical Center | New Orleans | Louisiana | 70112 | — |
| University of Maryland | Baltimore | Maryland | 21201 | — |
| Johns Hopkins University - IMPAACT Site | Baltimore | Maryland | 21287 | — |
| Children's Hospital of Michigan - IMPAACT Site | Detroit | Michigan | 48201 | — |
| UMDNJ - IMPAACT Site | Newark | New Jersey | 07103 | — |
| Mount Sinai Medical Center | New York | New York | 10128 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Duke Pediatric Infectious Diseases - IMPAACT Site | Durham | North Carolina | 27710 | — |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| St. Jude Children's Research Hospital (Memphis) - IMPAACT Site | Memphis | Tennessee | 38105 | — |
| St. Jude Childrens Research Hospital | Memphis | Tennessee | 38105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00491556, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 28, 2017 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00491556 live on ClinicalTrials.gov.